Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ralyath Balogoun"'
Autor:
Delphine Le Corre, Alexandre Ghazi, Ralyath Balogoun, Camilla Pilati, Thomas Aparicio, Séverine Martin-Lannerée, Laetitia Marisa, Fatima Djouadi, Virginie Poindessous, Carole Crozet, Jean-François Emile, Claire Mulot, Karine Le Malicot, Valérie Boige, Hélène Blons, Aurélien de Reynies, Julien Taieb, François Ghiringhelli, Jaafar Bennouna, Jean-Marie Launay, Pierre Laurent-Puig, Sophie Mouillet-Richard
Publikováno v:
EBioMedicine, Vol 46, Iss , Pp 94-104 (2019)
Background: Comprehensive transcriptomic analyses have shown that colorectal cancer (CRC) is heterogeneous and have led to the definition of molecular subtypes among which the stem-cell, mesenchymal-like group is associated with poor prognosis. The m
Externí odkaz:
https://doaj.org/article/40447755c68848f595bfc79fb34694ff
Autor:
Julien Taieb, C.-B. Levaché, Géraldine Perkins, K. Le Malicot, L. Saban-Roche, Gunnar Folprecht, John Bridgewater, Josep Tabernero, J. Thaler, J.F. Emile, J.-L. Van Laethem, Pierre Laurent-Puig, Enrico Mini, E. Van Cutsem, Côme Lepage, Ralyath Balogoun, Claire Mulot, Aziz Zaanan, S. Fratte, L.N. Petersen
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2017, 28 (4), pp.824-830. ⟨10.1093/annonc/mdw687⟩
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (4), pp.824-830. ⟨10.1093/annonc/mdw687⟩
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (4), pp.824-830. 〈https://academic.oup.com/annonc/article-abstract/28/4/824/2748099?redirectedFrom=fulltext〉. 〈10.1093/annonc/mdw687〉
Annals of Oncology, Elsevier, 2017, 28 (4), pp.824-830. ⟨10.1093/annonc/mdw687⟩
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (4), pp.824-830. ⟨10.1093/annonc/mdw687⟩
Annals of Oncology, Oxford University Press (OUP), 2017, 28 (4), pp.824-830. 〈https://academic.oup.com/annonc/article-abstract/28/4/824/2748099?redirectedFrom=fulltext〉. 〈10.1093/annonc/mdw687〉
IF 11.855; International audience; Background:RAS mutations have been shown to confer resistance to anti- epidermal growth factor receptor (EGFR) treatment. We analysed the results of the PETACC8 trial (cetuximab + FOLFOX vs FOLFOX) in full RAS and B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9601c234f9ac7ac8046b7dc8d8594d9e
https://hal.archives-ouvertes.fr/hal-01685765
https://hal.archives-ouvertes.fr/hal-01685765
Autor:
Camilla Pilati, Julien Taieb, Pierre Laurent-Puig, Ralyath Balogoun, A. de Reyniès, Laetitia Marisa
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 28(5)
Background Caudal-type homeobox transcription factor 2 (CDX2) is involved in colon cancer (CC) oncogenesis and has been proposed as a prognostic biomarker in patients with stage II or III CC. Patients and methods We analyzed CDX2 expression in a seri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef0569413d0cd690344bd9a97a74e651
https://pubmed.ncbi.nlm.nih.gov/28328000
https://pubmed.ncbi.nlm.nih.gov/28328000
Autor:
A. de Reyniès, Yuna Blum, Gérard Milano, Julien Taieb, Côme Lepage, Daniela Aust, Alex Duval, Valérie Boige, Camilla Pilati, R. Salazar, K. Le Malicot, Mira Ayadi, J.F. Seitz, Pierre Laurent-Puig, Laetitia Marisa, J.F. Emile, Janick Selves, Dominique Guenot, Ralyath Balogoun
Publikováno v:
Annals of Oncology. 29:viii18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2b23d6d1cc01e7a743a48c0a0ae9844
https://doi.org/10.1093/annonc/mdy269.058
https://doi.org/10.1093/annonc/mdy269.058
Autor:
Claire Mulot, Eric Van Cutsem, Julien Taieb, François Emile Jean, John Bridgewater, Karine Le Malicot, Gunnar Folprecht, Pierre Michel, Luc Van Laethem Jean, Ralyath Balogoun, Côme Lepage, Géraldine Perkins, Raphael Kourie Hampig, Olivier Bouché, Enrico Mini, Pierre Laurent Puig, Josef Thaler, Josep Tabernero, Ramon Salazar, Thomas Aparicio
Publikováno v:
Annals of Oncology. 28:iii142
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fadd65459593bbbfdfb0ac01f665714
https://doi.org/10.1093/annonc/mdx262.014
https://doi.org/10.1093/annonc/mdx262.014
Autor:
Julien Taieb, Jean-François Emile, Thomas Aparicio, Claire Mulot, Pierre Laurent-Puig, Josep Tabernero, Hampig Raphael Kourie, John Bridgewater, Jean-Luc Van Laethem, Ralyath Balogoun, Ramon Salazar, Enrico Mini, Pierre Michel, Côme Lepage, Karine Le Malicot, Gunnar Folprecht, Josef Thaler, Géraldine Perkins, Eric Van Cutsem, Olivier Bouché
Publikováno v:
JAMA oncology
JAMA oncology, American Medical Association, 2017, 〈https://jamanetwork.com/journals/jamaoncology/article-abstract/2663951?redirect=true〉. 〈10.1001/jamaoncol.2017.3695〉
Dipòsit Digital de la UB
Universidad de Barcelona
JAMA oncology, American Medical Association, 2018, 4 (7), pp.e173695. ⟨10.1001/jamaoncol.2017.3695⟩
JAMA oncology, American Medical Association, 2017, 〈https://jamanetwork.com/journals/jamaoncology/article-abstract/2663951?redirect=true〉. 〈10.1001/jamaoncol.2017.3695〉
Dipòsit Digital de la UB
Universidad de Barcelona
JAMA oncology, American Medical Association, 2018, 4 (7), pp.e173695. ⟨10.1001/jamaoncol.2017.3695⟩
IMPORTANCE: We know of no data on the prognostic value of primary tumor location (PTL) according to BRAF, RAS, and microsatellite instability (MSI) status in patients who have undergone resection for colon cancer (CC) and have been treated with curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::167906f3ccc020820b45c932a4588a5e
https://doi.org/10.1200/jco.2017.35.15_suppl.3515
https://doi.org/10.1200/jco.2017.35.15_suppl.3515
Autor:
Julien Taieb, Jean-François Emile, Camilla Pilati, Valérie Boige, Karine Le Malicot, Pierre Laurent-Puig, Laetitia Marisa, Janick Selves, Alex Duval, Côme Lepage, Mira Ayadi, Daniela Aust, Gérard Milano, Ralyath Balogoun, Aurélien de Reyniès, Dominique Guenot, Jean-François Seitz, Ramon Salazar
Publikováno v:
Journal of Clinical Oncology. 35:3509-3509
3509 Background: The molecular subtyping of colon cancers (CC) has been the subject of several recent publications, leading to an international consensus. The clinical relevance of these molecular classifications remains to be evaluated on large pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4231ed788e2aff3db553b3fc89351a0
https://doi.org/10.1200/jco.2017.35.15_suppl.3509
https://doi.org/10.1200/jco.2017.35.15_suppl.3509
Autor:
Julien Taieb, L. Nørgård Petersen, Anne Cayre, J-F. Ramé, J. Tabernero, Christophe Locher, K. Le Malicot, G. Folprecht, John Bridgewater, Ralyath Balogoun, J. Thaler, Frédérique Penault-Llorca, J-L. van Laethem, Pierre Laurent-Puig, C. Lagorce, S. Ellis, Côme Lepage, Enrico Mini, Eduardo Sánchez
Publikováno v:
Annals of Oncology. 27:vi151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc66dbc0fcd3e8a62c65b0e6aacb455c
https://doi.org/10.1093/annonc/mdw370.08
https://doi.org/10.1093/annonc/mdw370.08
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.